ArticleExperimental and therapeutic medicine2022

ALK‑positive locally advanced lung cancer in a patient who achieved long‑term complete response with crizotinib: A case report.

Levent Emirzeoglu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.